With increasing technological advances in access and utilization of healthcare and rising burden on limited resources, prioritization in healthcare becomes unavoidable. Health economics and outcomes research (HEOR) is a discipline used to complement conventional clinical development data (i.e., efficacy, safety, quality) in order to guide decision making process regarding patient access to specific drugs and services. We at FirstView, are empowered by our in-depth understanding of health economics and outcomes. We collaborate with customers to design and implement HEOR strategies to support pharmaceutical products throughout their life cycles.
Our team adopts a multidisciplinary approach to generate relevant economic and humanistic evidence for a variety of healthcare stakeholders, health authorities, payers and technology assessment agencies. Our systematic and targeted literature reviews are focused on the disease overview, humanistic and economic burden of disease including the direct and indirect costs, treatment pathways, comparator profiling and patient reported outcomes etc.